DNA damage inducible transcript 3 ; Homo sapiens






2317 Article(s)
Download
PMID
Title
Journal
Pub. Date
#Total Relationship(s)
1 84706 Superiority of adriamycin-containing combination chemotherapy in the treatment of diffuse lymphoma: a Southwest Oncology Group study. Cancer 1979 Feb 2
2 364284 Improvement in complete response rate, duration of response and survival with adriamycin combination chemotherapy for non-Hodgkin lymphoma: a prognostic factor comparison of two regimens. Med Pediatr Oncol 1978 1
3 1383819 Comparison of a second-generation combination chemotherapeutic regimen (m-BACOD) with a standard regimen (CHOP) for advanced diffuse non-Hodgkin's lymphoma. N Engl J Med 1992 Nov 5 2
4 1400365 Calcium ionophore A23187 induces expression of the growth arrest and DNA damage inducible CCAAT/enhancer-binding protein (C/EBP)-related gene, gadd153. Ca2+ increases transcriptional activity and mRNA stability. J Biol Chem 1992 Oct 5 11
5 1434294 [Renal lymphoma. Report of 2 cases and review of the literature]. Nihon Hinyokika Gakkai Zasshi 1992 Sep 1
6 1453209 Salvage therapy with ProMACE-MOPP followed by intensive chemoradiotherapy and autologous bone marrow transplantation for patients with non-Hodgkin's lymphoma who failed to respond to first-line CHOP. J Clin Oncol 1992 Dec 1
7 1533370 Abnormal uptake of technetium-99m hexakis-2-methoxyisobutylisonitrile in a primary cardiac lymphoma. Eur J Nucl Med 1992 1
8 1607914 Prognosis and treatment of lymphoblastic lymphoma in adults: a report on 80 patients. J Clin Oncol 1992 Jul 1
9 1630019 [Multiple myeloma in a patient in remission from malignant lymphoma]. Rinsho Ketsueki 1992 May 4
10 1637948 Platelet-activating factor mediates phosphatidylcholine hydrolysis by phospholipase D in human endometrium. Biol Reprod 1992 Jul 2
11 1699008 [The COP-BLAM therapy for malignant lymphoma]. Rinsho Ketsueki 1990 Jul 1
12 1703327 [Non-Hodgkin's lymphomas. Results of alternating chemotherapy versus sequential chemotherapy]. Sangre (Barc) 1990 Aug 3
13 1704933 [Assessment of the antitumor effect after remission induction therapy for non-Hodgkin's lymphoma--an approach to a response-adapted therapy]. Rinsho Ketsueki 1990 Nov 1
14 1708910 [CHOP-bleo versus m-BACOD in the treatment of intermediate and high-grade malignant lymphomas]. Rev Invest Clin 1990 Oct-Dec 1
15 1727386 Activation of the gadd153 promoter by genotoxic agents: a rapid and specific response to DNA damage. Cancer Res 1992 Jan 1 1
16 1735464 Cell growth inhibition by prostaglandin A2 results in elevated expression of gadd153 mRNA. Exp Cell Res 1992 Mar 16
17 2014946 Prognostic value of serum beta-2 microglobulin in low-grade lymphoma. Ann Intern Med 1991 May 15 3
18 2016618 Comparison of chlorambucil and prednisone versus cyclophosphamide, vincristine, and prednisone as initial treatment for chronic lymphocytic leukemia: long-term follow-up of an Eastern Cooperative Oncology Group randomized clinical trial. J Clin Oncol 1991 May 1
19 2029186 [Similar efficacy of less than 6 and 7-10 courses of therapy with anthracycline-based combination chemotherapy for localized non-Hodgkin's lymphoma of extranodal type]. Gan To Kagaku Ryoho 1991 May 1
20 2182600 Management of chronic lymphocytic leukemia. Hematol Oncol Clin North Am 1990 Apr 2
21 2190676 Vincristine infusion with CHOP-CCNU in diffuse large-cell lymphoma. Cancer Invest 1990 3
22 2246824 [Prominent lymphadenopathy and double Ph1 chromosomes as initial and recurrent manifestations of chronic myelogenous leukemia in blast crisis: report of a case and review of the literature]. Rinsho Ketsueki 1990 Sep 3
23 2317752 Continuous cyclophosphamide, doxorubicin, vincristine, and prednisolone. A new, innovative protocol for diffuse aggressive lymphomas. Cancer 1990 Apr 15 4
24 2361941 An operon containing the genes for cholesterol oxidase and a cytochrome P-450-like protein from a Streptomyces sp. J Bacteriol 1990 Jul 2
25 2428947 A 10-year update of CHOP-Bleo in the treatment of diffuse large-cell lymphoma. J Clin Oncol 1986 Oct 1
26 2464185 [Invasive thymoma with pulmonary metastasis. Complete remission 5 years after surgery and chemotherapy using the CHOP-BLEO protocol]. Rev Mal Respir 1988 2
27 2466548 Chemotherapy of invasive thymoma. A retrospective study of 22 cases. Cancer 1989 Apr 15 1
28 2481844 [Modified CHOP-Bleo protocol in the treatment of malignant non-Hodgkin's lymphoma of low cell differentiation]. Pol Arch Med Wewn 1988 Dec 1
29 2481974 [Priapism with malignant lymphoma: a case report]. Hinyokika Kiyo 1989 Oct 1
30 2523211 Prolymphocytic leukemia with suppressor T-cell phenotype: report of two cases. Anticancer Res 1989 Jan-Feb 1
31 2601224 [Partial remission of pulmonary metastasis of malignant gonadal stromal tumor by salvage chemotherapy]. Nihon Hinyokika Gakkai Zasshi 1989 Oct 1
32 2681883 [Chemotherapy of stage III-IV Hodgkin's disease. A retrospective analysis of the 53 cases collected from 9 institutions in Japan]. Rinsho Ketsueki 1989 Jul 2
33 3060443 Dose-intensity analysis for CHOP chemotherapy in diffuse aggressive large cell lymphoma. Isr J Med Sci 1988 Sep-Oct 1
34 3080220 Chemotherapy of malignant thymoma. Case report and review of the literature. Cancer 1986 Mar 15 1
35 3167803 Mediastinal large cell lymphoma. An uncommon subset of adult lymphoma curable with combined modality therapy. Cancer 1988 Nov 1 3
36 3203011 Treatment of diffuse histiocytic and diffuse mixed non-Hodgkin lymphomas with cyclophosphamide, doxorubicin, vincristine and prednisone (CHOP). Acta Oncol 1988 3
37 3581030 Cyclophosphamide, vincristine, adriamycin, and prednisone (CHOP) with and without intermediate dose methotrexate for the treatment of non-Hodgkin's lymphomas of diffuse histology. Cancer 1987 Jul 1 2
38 3751969 The importance of dose intensity of doxorubicin administration in non-Hodgkin's lymphoma. A case report. Am J Clin Oncol 1986 Aug 2
39 3754070 Primary brain malignant non-Hodgkin lymphoma: report of a case treated with chemotherapy in combination with radiotherapy. Tumori 1986 Feb 28 1
40 3827258 [Salvage chemotherapy of non-Hodgkin's lymphoma with a four-drug combination of mitoxantrone, etoposide, cisplatin and prednisolone (MEPP)]. Gan To Kagaku Ryoho 1987 Mar 1
41 3840280 Non-Hodgkin's lymphoma in pregnancy. South Med J 1985 Oct 4
42 3897470 Phase III study of BCOP v CHOP in unfavorable categories of malignant lymphoma: a Southeastern Cancer Study Group trial. J Clin Oncol 1985 Sep 1
43 6090736 A case of Japanese Burkitt's lymphoma associated with EB virus. Jpn J Clin Oncol 1984 Sep 2
44 6185212 Improved complete remission rates and survival for patients with large cell lymphoma treated with chemoimmunotherapy. A Southwest Oncology Group Study. Cancer 1983 Mar 15 2
45 6186997 [Results of treatment of the lymphoblastic and immunoblastic malignant lymphomas using the CHOP-bleo protocol (cyclophosphamide, doxorubicin, vincristine, bleomycin and prednisolone)]. Pol Arch Med Wewn 1982 Jul-Aug 1
46 6189041 Long-term results of patients with advanced diffuse, non-Hodgkin's lymphoma treated with cyclophosphamide, doxorubicin, vincristine, prednisone and bleomycin (CHOP-Bleo). Oncology 1983 1
47 6191677 [Cyclophosphamide, adriamycin, vincristine, bleomycin and prednisolone (CHOP-Bleo) combination chemotherapy for advanced non-Hodgkin's lymphoma]. Gan To Kagaku Ryoho 1983 May 3
48 6347997 The combined modality therapy of diffuse histology non-Hodgkin's lymphoma with cyclophosphamide, adriamycin, vincristine, prednisone (CHOP) and total body irradiation. Int J Radiat Oncol Biol Phys 1983 Aug 5
49 6396563 [Aggressive chemotherapy in generalized eosinophilic granuloma in adults]. Onkologie 1984 Dec 1
50 6688200 Cyclophosphamide, doxorubicin, vincristine, and prednisone (CHOP) in patients with advanced Hodgkin's disease: a Southwest Oncology Group Phase II Study. Cancer Treat Rep 1983 Jul-Aug 2